-
Communities
-
Explore Vanderbilt communities
By latest
Featured community
Creative Data Solutions (CDS) is a Vanderbilt Shared Resource and has extensive experience in providing effective and robust solutions to challenges pertaining to research data using modern informatics and bioinformatics approaches.
-
- Resources
-
People
-
Publications
-
Explore publications
-
Keyword Connections
Connections to Oxidoreductases, N-Demethylating are shown below. Double-click or tap a node for more information.
Please note that publication matches are limited to 40 in this view. If you expected more, please view all publication matches for Oxidoreductases, N-Demethylating.
Members
- No matching connections
Resources
- No matching connections
Communities
- No matching connections
Publications
- Oral erythromycin and the risk of sudden death from cardiac causes.
Ray WA, Murray KT, Meredith S, Narasimhulu SS, Hall K, Stein CM
(2004) N Engl J Med 351: 1089-96 - Identification of folate binding protein of mitochondria as dimethylglycine dehydrogenase.
Wittwer AJ, Wagner C
(1980) Proc Natl Acad Sci U S A 77: 4484-8 - Pharmacogenetics of plasma efavirenz exposure after treatment discontinuation: an Adult AIDS Clinical Trials Group Study.
Ribaudo HJ, Haas DW, Tierney C, Kim RB, Wilkinson GR, Gulick RM, Clifford DB, Marzolini C, Fletcher CV, Tashima KT, Kuritzkes DR, Acosta EP, Adult AIDS Clinical Trials Group Study
(2006) Clin Infect Dis 42: 401-7 - Efavirenz and CYP2B6 polymorphism: implications for drug toxicity and resistance.
Nolan D, Phillips E, Mallal S
(2006) Clin Infect Dis 42: 408-10 - Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity.
Ritchie MD, Haas DW, Motsinger AA, Donahue JP, Erdem H, Raffanti S, Rebeiro P, George AL, Kim RB, Haines JL, Sterling TR
(2006) Clin Infect Dis 43: 779-82 - Pharmacogenetics of nevirapine-associated hepatotoxicity: an Adult AIDS Clinical Trials Group collaboration.
Haas DW, Bartlett JA, Andersen JW, Sanne I, Wilkinson GR, Hinkle J, Rousseau F, Ingram CD, Shaw A, Lederman MM, Kim RB, Adult AIDS Clinical Trials Group
(2006) Clin Infect Dis 43: 783-6 - Cellular folate binding proteins; function and significance.
Wagner C
(1982) Annu Rev Nutr 2: 229-48 - Interactions of ingested food, beverage, and tobacco components involving human cytochrome P4501A2, 2A6, 2E1, and 3A4 enzymes.
Guengerich FP, Shimada T, Yun CH, Yamazaki H, Raney KD, Thier R, Coles B, Harris TM
(1994) Environ Health Perspect 102 Suppl 9: 49-53 - Elucidation of catalytic specificities of human cytochrome P450 and glutathione S-transferase enzymes and relevance to molecular epidemiology.
Guengerich FP, Shimada T, Raney KD, Yun CH, Meyer DJ, Ketterer B, Harris TM, Groopman JD, Kadlubar FF
(1992) Environ Health Perspect 98: 75-80 - CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphism.
Wandel C, Witte JS, Hall JM, Stein CM, Wood AJ, Wilkinson GR
(2000) Clin Pharmacol Ther 68: 82-91 - Impact of African herbal medicines on antiretroviral metabolism.
Mills E, Foster BC, van Heeswijk R, Phillips E, Wilson K, Leonard B, Kosuge K, Kanfer I
(2005) AIDS 19: 95-7 - CYP2B6 variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, Haiti.
Leger P, Dillingham R, Beauharnais CA, Kashuba AD, Rezk NL, Fitzgerald DW, Pape JW, Haas DW
(2009) J Infect Dis 200: 955-64 - Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmission.
Vardhanabhuti S, Acosta EP, Ribaudo HJ, Severe P, Lalloo U, Kumarasamy N, Taulo F, Kabanda J, Oneko O, Ive P, Sambarey P, Chan ES, Hitti J, Hong F, McMahon D, Haas DW, A5207 ACTG Study Team
(2013) J Infect Dis 208: 662-71 - Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African americans.
Haas DW, Gebretsadik T, Mayo G, Menon UN, Acosta EP, Shintani A, Floyd M, Stein CM, Wilkinson GR
(2009) J Infect Dis 199: 872-80 - Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group study.
Ribaudo HJ, Liu H, Schwab M, Schaeffeler E, Eichelbaum M, Motsinger-Reif AA, Ritchie MD, Zanger UM, Acosta EP, Morse GD, Gulick RM, Robbins GK, Clifford D, Haas DW
(2010) J Infect Dis 202: 717-22 - Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.
Kim RB, Wandel C, Leake B, Cvetkovic M, Fromm MF, Dempsey PJ, Roden MM, Belas F, Chaudhary AK, Roden DM, Wood AJ, Wilkinson GR
(1999) Pharm Res 16: 408-14 - Associations between HLA-DRB1*0102, HLA-B*5801, and hepatotoxicity during initiation of nevirapine-containing regimens in South Africa.
Phillips E, Bartlett JA, Sanne I, Lederman MM, Hinkle J, Rousseau F, Dunn D, Pavlos R, James I, Mallal SA, Haas DW
(2013) J Acquir Immune Defic Syndr 62: e55-7 - The amino acid sequences of the flavin-peptides of dimethylglycine dehydrogenase and sarcosine dehydrogenase from rat liver mitochondria.
Cook RJ, Misono KS, Wagner C
(1985) J Biol Chem 260: 12998-3002 - Identification of the covalently bound flavin of dimethylglycine dehydrogenase and sarcosine dehydrogenase from rat liver mitochondria.
Cook RJ, Misono KS, Wagner C
(1984) J Biol Chem 259: 12475-80 - Identification of the folate-binding proteins of rat liver mitochondria as dimethylglycine dehydrogenase and sarcosine dehydrogenase. Flavoprotein nature and enzymatic properties of the purified proteins.
Wittwer AJ, Wagner C
(1981) J Biol Chem 256: 4109-15 - Identification of the folate-binding proteins of rat liver mitochondria as dimethylglycine dehydrogenase and sarcosine dehydrogenase. Purification and folate-binding characteristics.
Wittwer AJ, Wagner C
(1981) J Biol Chem 256: 4102-8 - Pharmacokinetics of phase I nevirapine metabolites following a single dose and at steady state.
Fan-Havard P, Liu Z, Chou M, Ling Y, Barrail-Tran A, Haas DW, Taburet AM, ANRS12154 Study Group
(2013) Antimicrob Agents Chemother 57: 2154-60 - Genetic determinants of the ankle-brachial index: a meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe) consortium.
Wassel CL, Lamina C, Nambi V, Coassin S, Mukamal KJ, Ganesh SK, Jacobs DR, Franceschini N, Papanicolaou GJ, Gibson Q, Yanek LR, van der Harst P, Ferguson JF, Crawford DC, Waite LL, Allison MA, Criqui MH, McDermott MM, Mehra R, Cupples LA, Hwang SJ, Redline S, Kaplan RC, Heiss G, Rotter JI, Boerwinkle E, Taylor HA, Eraso LH, Haun M, Li M, Meisinger C, O'Connell JR, Shuldiner AR, Tybjærg-Hansen A, Frikke-Schmidt R, Kollerits B, Rantner B, Dieplinger B, Stadler M, Mueller T, Haltmayer M, Klein-Weigel P, Summerer M, Wichmann HE, Asselbergs FW, Navis G, Mateo Leach I, Brown-Gentry K, Goodloe R, Assimes TL, Becker DM, Cooke JP, Absher DM, Olin JW, Mitchell BD, Reilly MP, Mohler ER, North KE, Reiner AP, Kronenberg F, Murabito JM
(2012) Atherosclerosis 222: 138-47 - Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects.
Guengerich FP, Kim DH, Iwasaki M
(1991) Chem Res Toxicol 4: 168-79 - Genome-wide association study of plasma efavirenz pharmacokinetics in AIDS Clinical Trials Group protocols implicates several CYP2B6 variants.
Holzinger ER, Grady B, Ritchie MD, Ribaudo HJ, Acosta EP, Morse GD, Gulick RM, Robbins GK, Clifford DB, Daar ES, McLaren P, Haas DW
(2012) Pharmacogenet Genomics 22: 858-67 - Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose.
Johnson DH, Gebretsadik T, Shintani A, Mayo G, Acosta EP, Stein CM, Haas DW
(2013) Br J Clin Pharmacol 75: 997-1006 - Hydroperoxy-10,12-octadecadienoic acid stimulates cytochrome P450 3A protein aggregation by a mechanism that is inhibited by substrate.
Kimzey AL, Weitz KK, Guengerich FP, Zangar RC
(2003) Biochemistry 42: 12691-9 - Enzymatic properties of dimethylglycine dehydrogenase and sarcosine dehydrogenase from rat liver.
Porter DH, Cook RJ, Wagner C
(1985) Arch Biochem Biophys 243: 396-407 - Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties.
Gillam EM, Guo Z, Guengerich FP
(1994) Arch Biochem Biophys 312: 59-66 - Covalent binding of folic acid to dimethylglycine dehydrogenase.
Wagner C, Briggs WT, Cook RJ
(1984) Arch Biochem Biophys 233: 457-61 - Expression of human cytochrome P450 2B6 in Escherichia coli: characterization of catalytic activity and expression levels in human liver.
Hanna IH, Reed JR, Guengerich FP, Hollenberg PF
(2000) Arch Biochem Biophys 376: 206-16 - Selectivity of cytochrome P4502E1 in chlorzoxazone 6-hydroxylation.
Yamazaki H, Guo Z, Guengerich FP
(1995) Drug Metab Dispos 23: 438-40 - Mibefradil is a P-glycoprotein substrate and a potent inhibitor of both P-glycoprotein and CYP3A in vitro.
Wandel C, Kim RB, Guengerich FP, Wood AJ
(2000) Drug Metab Dispos 28: 895-8 - Differential induction of rat hepatic cytochromes P450 3A1, 3A2, 2B1, 2B2, and 2E1 in response to pyridine treatment.
Kim H, Putt DA, Zangar RC, Wolf CR, Guengerich FP, Edwards RJ, Hollenberg PF, Novak RF
(2001) Drug Metab Dispos 29: 353-60 - Measurement of dimethylglycine in biological fluids.
Porter DH, Lin M, Wagner C
(1985) Anal Biochem 151: 299-303 - Dimethylglycine dehydrogenase and sarcosine dehydrogenase: mitochondrial folate-binding proteins from rat liver.
Cook RJ, Wagner C
(1986) Methods Enzymol 122: 255-60
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.
